IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.

Research output: Contribution to journalArticle

Abstract

IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any influence on atherosclerosis development in mice.

Details

Authors
Organisations
External organisations
  • Malmö University
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cardiac and Cardiovascular Systems
Original languageEnglish
Article numbere0117255
JournalPLoS ONE
Volume10
Issue number1
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available